Therapeutic misconception—a false belief that individuals will benefit from participating in research—can bias informed consent. Ethics consultants can help by engaging participants’ and researchers’ understandings of risks and benefits and by asking good questions about the influences of researchers’ enthusiasm.

Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research.

Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness.

A guardian’s request to sterilize a woman with intellectual disabilities is not ethically justifiable unless the woman assents and it is to her benefit.

Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others.

Applications can identify and monitor patients. They can also diagnose genetic, medical, and behavioral conditions.

Shared decision making in research informed consent conversations is complex due to diverse and potentially divergent interests of investigators and patient-subjects.

Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.

Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation.

Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion.